Assessing the participant experience with fibrodysplasia ossificans progressiva: qualitative interviews from the optima trial

Authors
Category Primary study
Conference33rd European Paediatric Rheumatology Congress
Year 2026
This article has no abstract
Epistemonikos ID: 8d0eb8c8bf5c994281b2398e72e569c0f6894907
First added on: Oct 24, 2026